EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV

Lena van der Wekken-Pas iD, Fabian Weiss, Charlotte Simon-Zuber, Rena Sebisch, Carmen Wiese, Elisabeth van Leeuwen, David Burger, Angela Colbers

Clinical Infectious Diseases · 17.12.2024 · 79 (6) · 1468-1471

DOI: 10.1093/cid/ciae242 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 03.05.2024. Verfasst von Lena van der Wekken-Pas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI), Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: HIV Infections, Pyridones, Rilpivirine, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case report describes the effects of bimonthly long-acting injectable cabotegravir (CAB)/RPV before and throughout pregnancy. CAB concentrations were comparable to those in nonpregnant individuals; RPV concentrations were 70%–75% lower. No virologic failure or vertical transmission occurred. Despite placental transfer, no congenital malformations were noted. Bimonthly long-acting injectable CAB/RPV may not be suitable for pregnant women, and monitoring of exposed infants is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPyridonesRilpivirinePregnancy Complications, InfectiousAnti-HIV AgentsHumansFemalePregnancyAdultDiketopiperazines

Stichwörter der Autor:innen

HIVcabotegravirlong-acting injectablespregnancyrilpivirine

Substanzen

cabotegravirPyridonesRilpivirineAnti-HIV AgentsDiketopiperazines

Autor:innen und Institutionen

  • Department of Pharmacy, Radboud University Medical Center, Radboud Institute for Medical Innovations (RIMI), Nijmegen, The Netherlands.
  • Department of Obstetrics and Gynecology, LMU University Hospital, Munich, Germany.
  • Department of Internal Medicine, MVZ München am Goetheplatz, Munich, Germany.
  • Department of Gynecology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

ORCID-Profile: Lena van der Wekken-Pas

Zitieren

APA

van der Wekken-Pas, L., Weiss, F., Simon-Zuber, C., Sebisch, R., Wiese, C., van Leeuwen, E., Burger, D., & Colbers, A. (2024). Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV. Clinical Infectious Diseases, 79(6), 1468-1471. https://doi.org/10.1093/cid/ciae242

Vancouver

van der Wekken-Pas L, Weiss F, Simon-Zuber C, Sebisch R, Wiese C, van Leeuwen E, et al. Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV. Clinical Infectious Diseases. 2024;79(6):1468-1471. doi:10.1093/cid/ciae242

BibTeX
@article{vanderWekkenPas2024,
  author = {van der Wekken-Pas, Lena and Weiss, Fabian and Simon-Zuber, Charlotte and Sebisch, Rena and Wiese, Carmen and van Leeuwen, Elisabeth and Burger, David and Colbers, Angela},
  title = {Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {6},
  pages = {1468--1471},
  doi = {10.1093/cid/ciae242}
}
Kostenlos starten →